Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats

Fig. 2

Proposed metabolite structures and metabolic pathways for cryptolepine determined by LC-MS/MS after incubation with rat and human hepatocytes for up to 24 h and in plasma and urine of SD rats after single dose oral administration of cryptolepine. R: detected after rat hepatocyte incubation; H: detected after human hepatocyte incubation. * Metabolite detected in rat urine; ** metabolite detected in rat urine and plasma

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us